Surrounded by a dynamic academic and business environment, Cambridge continues to invest in underpinnig the science base, committing to boost UK spending on R&D to 2.4% GDP by 2027 and rising to 3% with an additional £ 4bn invested in R&D since 2017.
Cambridge has a long history of world‑leading life sciences research and development in the UK and it is a major area of focus to ensure that promising health and life sciences companies can reach their fully potential.
The Life Sciences Industrial Strategy set out a vision to deliver future growth for the sector and highlighted opportunities for the UK to build on its strengths in order to remain globally competitive.